<DOC>
	<DOCNO>NCT00119626</DOCNO>
	<brief_summary>This study determine NXY-059 reduce functional disability acute stroke . The study design look overall recovery recovery motor function , example muscle strength coordination .</brief_summary>
	<brief_title>Safety Effectiveness NXY-059 Treatment Patients Who Have Suffered From Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<mesh_term>Disufenton sodium</mesh_term>
	<criteria>Males female Acute ischemic stroke limb weakness , onset symptom within 6 hour Full functional independence prior present stroke Unconsciousness Subjects unlikely complete infusion investigational product and/or unlikely undergo active medical management period due severe clinical condition Severe illness life expectancy le 6 month Known severe kidney disorder Current know alcohol illicit drug abuse dependence Pregnant breastfeeding Treatment acetazolamide methotrexate permit infusion Participation previous clinical study within 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Stroke , Acute</keyword>
	<keyword>Cerebrovascular Stroke</keyword>
</DOC>